These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6863572)

  • 41. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
    Palangie T; Jouve M; Giralt E; Bretaudeau B; Pouillart P
    Bull Cancer; 1983; 70(5):437-8. PubMed ID: 6582941
    [No Abstract]   [Full Text] [Related]  

  • 43. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of multiple myeloma.
    Kyle RA; Maldonado JE; Bayrd ED
    Mayo Clin Proc; 1968 Oct; 43(10):730-7. PubMed ID: 5711940
    [No Abstract]   [Full Text] [Related]  

  • 46. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
    Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
    Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
    González Larriba JL; Alberola V; Lianes P; Panizo A; Carrato A; Muñoz Quintana A; Cardenal F; Gracia JM; Moyano A; Díaz-Rubio E
    Rev Clin Esp; 1994 Nov; 194(11):953-9. PubMed ID: 7846351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
    Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thalidomide for the treatment of leptomeningeal multiple myeloma.
    Yutaka H; Mariko Y; Shinichiro O; Kunihiko M; Yusuke T; Yasuo I
    Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710
    [No Abstract]   [Full Text] [Related]  

  • 53. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
    Joss RA; Brunner KW; Goldhirsch A
    Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
    [No Abstract]   [Full Text] [Related]  

  • 54. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
    Yang X; Yang C; Shao K; Ye X; Meng H; Zhou Y; Qian W
    Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
    Pavlovsky S; Saslavsky J; Tezanos Pinto M; Palmer L; Curuchet M; Lein JM; Garay G; Dragosky M; Quiroga-Micheo E; Huberman AB
    J Clin Oncol; 1984 Jul; 2(7):836-40. PubMed ID: 6376722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further progress in the treatment of multiple myeloma?
    Malik PS; Kumar L
    Natl Med J India; 2009; 22(1):25-7. PubMed ID: 19761157
    [No Abstract]   [Full Text] [Related]  

  • 57. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
    Bollag W
    Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076
    [No Abstract]   [Full Text] [Related]  

  • 58. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prospects of new chemotherapies].
    Sculier JP; Klastersky J
    Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
    [No Abstract]   [Full Text] [Related]  

  • 60. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.